75 related articles for article (PubMed ID: 7913110)
1. Structure-function studies of anti-3-fucosyllactosamine (Le(x)) and galactosylgloboside antibodies.
Snyder JG; Dinh Q; Morrison SL; Padlan EA; Mitchell M; Yu-Lee LY; Marcus DM
J Immunol; 1994 Aug; 153(3):1161-70. PubMed ID: 7913110
[TBL] [Abstract][Full Text] [Related]
2. Sequences of the VH and VL regions of murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Cook R; Meek K; Umeda M; Ball E; Capra JD; Marcus DM
J Immunol; 1988 Feb; 140(4):1212-7. PubMed ID: 2893825
[TBL] [Abstract][Full Text] [Related]
3. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
4. Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine.
Kimura H; Buescher ES; Ball ED; Marcus DM
Eur J Immunol; 1989 Sep; 19(9):1741-6. PubMed ID: 2571506
[TBL] [Abstract][Full Text] [Related]
5. Heavy and light chain sequences of four monoclonal antibodies that bind galactosylgloboside (GalGb4).
Snyder JG; Weng N; Yu-Lee LY; Marcus DM
Eur J Immunol; 1990 Dec; 20(12):2673-7. PubMed ID: 2125273
[TBL] [Abstract][Full Text] [Related]
6. High affinity antibodies against Lex and sialyl Lex from a phage display library.
Dinh Q; Weng NP; Kiso M; Ishida H; Hasegawa A; Marcus DM
J Immunol; 1996 Jul; 157(2):732-8. PubMed ID: 8752923
[TBL] [Abstract][Full Text] [Related]
7. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity.
Pewzner-Jung Y; Simon T; Eilat D
J Immunol; 1996 Apr; 156(8):3065-73. PubMed ID: 8609430
[TBL] [Abstract][Full Text] [Related]
8. Modulation of antibody affinity by an engineered amino acid substitution.
Wong YW; Kussie PH; Parhami-Seren B; Margolies MN
J Immunol; 1995 Apr; 154(7):3351-8. PubMed ID: 7897218
[TBL] [Abstract][Full Text] [Related]
9. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation.
Rohatgi S; Dutta D; Tahir S; Sehgal D
J Immunol; 2009 May; 182(9):5570-85. PubMed ID: 19380805
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
[TBL] [Abstract][Full Text] [Related]
13. Cardiolipin binding a light chain from lupus-prone mice.
Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
[TBL] [Abstract][Full Text] [Related]
14. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
15. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
16. The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme.
Hawkins RE; Russell SJ; Baier M; Winter G
J Mol Biol; 1993 Dec; 234(4):958-64. PubMed ID: 8263942
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a T cell line specific to an anti-Id antibody related to the carbohydrate antigen, sialyl SSEA-1, and the immundominant T cell antigenic site of the antibody.
Tsuyuoka K; Yago K; Hirashima K; Ando S; Hanai N; Saito H; Yamasaki KM; Takahashi K; Fukuda Y; Nakao K; Kannagi R
J Immunol; 1996 Jul; 157(2):661-9. PubMed ID: 8752915
[TBL] [Abstract][Full Text] [Related]
18. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding.
Zhang M; Majid A; Bardwell P; Vee C; Davidson A
J Immunol; 1998 Sep; 161(5):2284-9. PubMed ID: 9725222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
